About Compendia Bioscience
Compendia Bioscience is a Healthcare company based in Ann Arbor (United States) founded in 2006, and was acquired by Life Technologies in October 2012. Genomic data and tools are offered for oncology biomarker discoveries. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis.
Company details
Compendia Bioscience was founded in 2006 in Ann Arbor, United States, within the bioscience sector. Genomic data and analysis tools are provided for biomarker and gene target identification, primarily in oncology. Operations include web applications such as Oncomine editions for cancer profiling, OncoScore for patient stratification in clinical trials, OncoPredictor tools for biomarker evaluation across preclinical and clinical populations, and solutions for target validation through genomic aberrations and expression analysis.
- Headquarters Ann Arbor, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website thermofisher.com/in/en/home/life-science/cancer-research/cancer-genomics/oncomine-informatics.html
- Social LinkedIn
- Acquired by Life Technologies (Oct 2012)
- Latest Funding Round$2.4M (USD), Grant
Oct 2007
- InvestorsLife Technologies
& 1 more
- Acquired byLife Technologies
(Oct 2012)
Funding Insights of Compendia Bioscience
- Total Rounds 1
- Last Round Grant — $2.4M
- First Round $2.4M
(Oct 2007)
- Investors Count 1
All 1 funding rounds of Compendia Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2007 | $2.4M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Compendia Bioscience
Compendia Bioscience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Life Technologies and NIH SBIR/STTR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| sbir.nih.gov | ||||
Tools and technologies for biotech and biopharma research were supplied. | 1983 | lifetechnologies.com | Carlsbad, United States |
Investor details for Compendia Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Compendia Bioscience
3 dated milestones of Compendia Bioscience across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Compendia Bioscience is founded.
- Funding First funding round of $2.4M.
- Exit Acquired by Life Technologies.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Compendia Bioscience (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Compendia Bioscience
Compendia Bioscience was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Compendia Bioscience is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Compendia Bioscience was founded in 2006 in Ann Arbor, United States, within the bioscience sector. Genomic data and analysis tools are provided for biomarker and gene target identification, primarily in oncology. Operations include web applications such as Oncomine editions for cancer profiling, OncoScore for patient stratification in clinical trials, OncoPredictor tools for biomarker evaluation across preclinical and clinical populations, and solutions for target validation through genomic aberrations and expression analysis.
Compendia Bioscience has 2 investors. Key investors include Life Technologies, and NIH SBIR/STTR.
Yes. Compendia Bioscience was acquired by Life Technologies in October 2012.